Treatment persistence of biologics among patients with psoriatic arthritis

BACKGROUND: Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an important factor in individualized patient treatment planning and healthcare policy and guideline development. OBJECTIVE: To estimate the persistence of biologic agents prescribed to PsA patients in a real-life s...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Amir, Gazitt, Tal, Feldhamer, Ilan, Feld, Joy, Cohen, Arnon Dov, Lavi, Idit, Tatour, Faten, Bergman, Irena, Zisman, Devy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845003/
https://www.ncbi.nlm.nih.gov/pubmed/33514410
http://dx.doi.org/10.1186/s13075-021-02417-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845003/
https://www.ncbi.nlm.nih.gov/pubmed/33514410
http://dx.doi.org/10.1186/s13075-021-02417-x

Ejemplares similares